Suppliers / Cspc Innovation Pharm

Cspc Innovation Pharm

China Updated 9 July 2026

Cspc Innovation Pharm is an API manufacturer based in China. It holds 2 active US drug master files across a filed portfolio of 2 molecules.

2
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Caffeine US FDA 1
Pentoxifylline US FDA 1

Also appears on these molecule pages

Caffeine API Pentoxifylline API

Questions about Cspc Innovation Pharm

Does Cspc Innovation Pharm hold a US DMF or a CEP?
Cspc Innovation Pharm holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Cspc Innovation Pharm make?
2 molecules are on record against Cspc Innovation Pharm, including Caffeine and Pentoxifylline. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Cspc Innovation Pharm comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Siegfried shares 1 molecule Solara Active Pharma Sciences shares 1 molecule Hikal shares 1 molecule Shandong Xinhua Pharmaceutical shares 1 molecule Zaklady Farmaceutyczne Polpharma shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability